Table 2.
Characteristic | Patients with chart review, % (n = 108) | Patients with computerized data, % (n = 28,601) |
---|---|---|
Sexa | ||
Men | 19 | 26 |
Women | 81 | 74 |
Age group, yearsb | ||
18–39 | 18 | 7 |
40–49 | 12 | 11 |
50–59 | 24 | 19 |
60–69 | 23 | 22 |
70–89 | 23 | 41 |
Race/ethnicity | ||
White | 53 | 57 |
Hispanic | 17 | 16 |
Black | 10 | 8 |
Asian | 12 | 8 |
Unknown/other | 8 | 11 |
Antibody positivity | ||
Rheumatoid factor positive | 69 | — |
Anticyclic citrullinated peptide antibody positive | 24 | — |
Radiographic evidence | ||
Juxta-articular osteopenia | 15 | — |
Soft-tissue/fusiform swelling | 4 | — |
Joint space narrow | 17 | — |
Periarticular erosions | 14 | — |
Subluxations | 7 | — |
Comorbid gout | 6 | — |
Joint involvement | ||
Shoulder, elbows | 12 | — |
Knees | 20 | — |
Ankles | 18 | — |
Metacarpophalangeal (MPT) joints | 27 | — |
Proximal interphalangeal joints | 32 | — |
Second through fifth MPT joints | 17 | — |
Wrist | 37 | — |
Hands | 15 | — |
Feet | 6 | — |
Not recorded | 27 | — |
Number of involved small joints | ||
0–1 | 9 | — |
2 | 16 | — |
3–10 | 42 | — |
Not recorded | 33 | — |
Disease duration, years | ||
0–4 | 25 | — |
5–9 | 14 | — |
10–19 | 31 | — |
≥ 20 | 23 | — |
Unknown | 6 | — |
p = 0.16.
p < 0.01.
— = not available.